COVID-19 and Pregnancy: Factors Associated with the Occurrence of COVID-19 during Pregnancy, Maternal and Perinatal Outcome in Two Referral Hospitals in the City of Douala, Cameroon
Introduction: The Coronavirus pandemic was responsible for an unprecedented health crisis that shook the world with its high contagiousness and lethality. Its impact on maternal and fetal health places pregnant women at high risk. The aim of our study was to determine the factors associated with the occurrence of COVID-19 in pregnant women, and the maternal and perinatal outcomes of infected patients. Methodology: This was a case-control study involving 42 cases matched to 42 controls recruited from two public and tertiary hospitals in the cities of Yaoundé and Douala over a period from November 31 to May 31, 2024. Cases were defined as deliveries or records of COVID-19 deliveries confirmed positive by reverse transcription polymerase chain reaction (RT-PCR) or by a COVID-19 rapid diagnostic test (Covid-RDT). Controls were defined as deliveries or records of deliveries negative to the same test. They were matched by the hospital. Non-consenting births and unusable records were excluded. The data collected were recorded on a pre-established, pretexted data sheet examining sociodemographic, clinical characteristics and maternal and perinatal outcomes which were then analyzed using SPSS version 23.0 software. Results: After multivariate analysis, the independent sociodemographic factors were: belonging to the [30 - 40] age group (OR: 4.4; P = 0.010), being married (OR: 8.1; P = 0.030); being unemployed (OR: 3; P = 0.040). Independent clinical factors were: being in the third trimester of pregnancy (OR: 1.1; P = 0.017), being diabetic (OR: 5; P = 0.033) and being obese (OR: 11.5; P = 0.043). Independent factors associated with maternal outcome were: caesarean section (OR: 10; P = 0.001); admission to intensive care (OR: 30.7; P = 0.013); SO2 ≤ 94% (OR: 11.7; P = 0.033); HR > 100 (OR: 15.5; P = 0.001). Independent factors associated with perinatal outcome were: weight < 2500 (OR: 12; P = 0.039); APGAR score (OR: 15; P = 0.030). Conclusion: The factors associated with the occurrence of COVID-19 in pregnant women are multiple, and maternal outcome depends on its condition on admission, and has a significant impact on perinatal health, including mode of delivery. Emphasis must be placed on prevention and optimal management of these associated factors.
References
[1]
World Health Organization. Coronavirus Disease (COVID-2019) Situation Reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
[2]
Organisation mondiale de la santé (OMS) (2020) COVID-19 infos: Bulletin d’information de l’OMS Cameroun. n° 2. https://www.afro.who.int
[3]
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020) Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine, 382, 1199-1207.
[4]
Knight, M., Bunch, K., Vousden, N., Morris, E., Simpson, N., Gale, C., et al. (2020) Characteristics and Outcomes of Pregnant Women Admitted to Hospital with Confirmed SARS-CoV-2 Infection in UK: National Population Based Cohort Study. BMJ, 369, m2107. https://doi.org/10.1136/bmj.m2107
[5]
Ferrazzi, E.M., Frigerio, L., Cetin, I., Vergani, P., Spinillo, A., Prefumo, F., et al. (2020) Covid‐19 Obstetrics Task Force, Lombardy, Italy: Executive Management Summary and Short Report of Outcome. InternationalJournalofGynecology&Obstetrics, 149, 377-378. https://doi.org/10.1002/ijgo.13162
[6]
Asadi, L., Tabatabaei, R.S., Safinejad, H. and Mohammadi, M. (2020) New Corona Virus (COVID-19) Management in Pregnancy and Childbirth. ArchivesofClinicalInfectiousDiseases, 15, Article ID: 102938. https://doi.org/10.5812/archcid.102938
[7]
Rigby, F.B. and Pastorek, J.G. (1996) Pneumonia during Pregnancy. ClinicalObstetricsandGynecology, 39, 107-119. https://doi.org/10.1097/00003081-199603000-00011
[8]
Peyronnet, V., Sibiude, J., Deruelle, P., Huissoud, C., Lescure, X., Lucet, J., et al. (2020) Infection par le SARS-CoV-2 chez les femmes enceintes: État des connaissances et proposition de prise en charge par CNGOF. GynécologieObstétriqueFertilité&Sénologie , 48, 436-443. https://doi.org/10.1016/j.gofs.2020.03.014
[9]
Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., et al. (2020) Clinical Manifestations, Risk Factors, and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-analysis. BMJ, 370, m3320. https://doi.org/10.1136/bmj.m3320
[10]
Wu, Y., Ho, W., Huang, Y., Jin, D., Li, S., Liu, S., et al. (2020) SARSCoV-2 Is an Appropriate Name for the New Coronavirus. TheLancet, 395, 949-950. https://doi.org/10.1016/s0140-6736(20)30557-2
[11]
Poon, L.C., Yang, H., Lee, J.C.S., Copel, J.A., Leung, T.Y., Zhang, Y., et al. (2020) ISUOG Interim Guidance on 2019 Novel Coronavirus Infection during Pregnancy and Puerperium: Information for Healthcare Professionals. UltrasoundinObstetrics&Gynecology, 55, 700-708. https://doi.org/10.1002/uog.22013
[12]
Chi, J., Gong, W. and Gao, Q. (2020) Clinical Characteristics and Outcomes of Pregnant Women with COVID-19 and the Risk of Vertical Transmission: A Systematic Review. ArchivesofGynecologyandObstetrics, 303, 337-345. https://doi.org/10.1007/s00404-020-05889-5
[13]
Ngalame, A.N., Neng, H.T., Inna, R., Djomo, D.T., Kamdem, D.E.M., Moustapha, B., et al. (2020) Materno-Fetal Outcomes of COVID-19 Infected Pregnant Women Managed at the Douala Gyneco-Obstetric and Pediatric Hospital—Cameroon. OpenJournalofObstetricsandGynecology, 10, 1279-1294. https://doi.org/10.4236/ojog.2020.1090118
[14]
Pierce-Williams, R.A.M., et al. (2020) Clinical Course of Severe and Critical Coronavirus Disease 2019 in Hospitalized Pregnancies: A United States Cohort Study. American Journal of Obstetrics & Gynecology MFM, 2, Article ID: 100134.
[15]
Organisation mondiale de la santé. Flambée de maladie à coronavirus (Covid-19). https://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019
[16]
Communique n° 1050 du 16 janvier 2023 du ministere de la sante et du developpement social sur la covid-19.
[17]
Dembélé, S. (2022) Prise en charge de la femme enceinte infectée par le Covid-19: Aspects épidémiologiques, cliniques et pronostiques. Mémoire One Line Bamako.
[18]
Brun, A.L. (2022) Le verre dépoli: Ses variantes et leur signification. https://www.em-consulte.com/article/241777/le-verre-depoli-ses-varianteset-leur-significatio
[19]
(2021) Faut-il vacciner les femmes enceintes contre la Covid-19? Bulletin de l’Académie Nationale de Médecine, 205, 439-440.
[20]
Li, Y., Zhao, R.H., Zheng, S.F., Chen, X., et al. (2020) Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China. Emerging Infectious Diseases, 26, 1335-1336. https://doi.org/10.3201/eid2606.200287